Israel Englander’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69.9M Buy
+989,033
New +$53.4M 0.03% 705
2026
Q1
Sell
-15,323
Closed -$901K 6375
2025
Q4
$901K Sell
15,323
-190,293
-93% -$11.6M ﹤0.01% 4556
2025
Q3
$11.4M Sell
205,616
-1,435,033
-87% -$76.9M ﹤0.01% 2258
2025
Q2
$84.4M Buy
+1,640,649
New +$82.4M 0.04% 496
2025
Q1
Sell
-655,791
Closed -$47.2M 6390
2024
Q4
$47.2M Sell
655,791
-616,150
-48% -$45.2M 0.02% 814
2024
Q3
$102M Buy
1,271,941
+147,395
+13% +$11.1M 0.05% 408
2024
Q2
$80.6M Sell
1,124,546
-24,939
-2% -$1.84M 0.04% 517
2024
Q1
$80.9M Buy
1,149,485
+1,145,501
+28,753% +$82M 0.03% 568
2023
Q4
$307K Sell
3,984
-134,152
-97% -$8.84M ﹤0.01% 4949
2023
Q3
$9.4M Buy
138,136
+97,454
+240% +$7.7M ﹤0.01% 2108
2023
Q2
$3.32M Sell
40,682
-735,271
-95% -$59.1M ﹤0.01% 3043
2023
Q1
$57.6M Buy
775,953
+426,107
+122% +$32.8M 0.03% 607
2022
Q4
$29M Buy
349,846
+85,974
+33% +$6.83M 0.02% 1135
2022
Q3
$18.7M Buy
263,872
+236,264
+856% +$20.4M 0.01% 1407
2022
Q2
$2.39M Buy
27,608
+20,276
+277% +$1.9M ﹤0.01% 3509
2022
Q1
$794K Sell
7,332
-203,184
-97% -$21M ﹤0.01% 4750
2021
Q4
$27.2M Sell
210,516
-171,844
-45% -$21.1M 0.01% 1175
2021
Q3
$46.3M Buy
382,360
+346,188
+957% +$42.1M 0.03% 679
2021
Q2
$4.07M Sell
36,172
-692,632
-95% -$72.9M ﹤0.01% 3035
2021
Q1
$69.6M Buy
728,804
+464,972
+176% +$42.4M 0.05% 360
2020
Q4
$20.9M Buy
263,832
+31,804
+14% +$2.3M 0.02% 1029
2020
Q3
$14.4K Buy
232,028
+203,384
+710% +$13.2M 0.02% 992
2020
Q2
$1.89M Sell
28,644
-5,860
-17% -$351K ﹤0.01% 2581
2020
Q1
$1.64M Buy
34,504
+7,192
+26% +$360K ﹤0.01% 2156
2019
Q4
$1.5M Sell
27,312
-289,028
-91% -$15.2M ﹤0.01% 2781
2019
Q3
$15.5M Sell
316,340
-186,052
-37% -$9.33M 0.02% 965
2019
Q2
$26.2M Sell
502,392
-337,732
-40% -$17M 0.04% 635
2019
Q1
$41.7M Buy
840,124
+826,876
+6,242% +$37.2M 0.06% 409
2018
Q4
$479K Sell
13,248
-315,128
-96% -$13.2M ﹤0.01% 2996
2018
Q3
$16.8M Buy
+328,376
New +$14.5M 0.02% 936
2018
Q2
Sell
-280,212
Closed -$10.6M 4161
2018
Q1
$10.6M Buy
280,212
+5,824
+2% +$206K 0.01% 1288
2017
Q4
$8.89M Sell
274,388
-332,952
-55% -$10.6M 0.01% 1402
2017
Q3
$18.4M Buy
+607,340
New +$18M 0.03% 843
2017
Q2
Sell
-32,024
Closed -$814K 3859
2017
Q1
$814K Sell
32,024
-123,400
-79% -$3.19M ﹤0.01% 2523
2016
Q4
$4M Sell
155,424
-284,240
-65% -$7.47M 0.01% 1479
2016
Q3
$12M Buy
439,664
+348,524
+382% +$9.57M 0.02% 823
2016
Q2
$2.57M Sell
91,140
-367,236
-80% -$9.44M 0.01% 1648
2016
Q1
$10.8M Buy
458,376
+436,020
+1,950% +$9.6M 0.03% 785
2015
Q4
$503K Sell
22,356
-558,288
-96% -$12.7M ﹤0.01% 2640
2015
Q3
$13.4M Buy
580,644
+509,656
+718% +$12.8M 0.03% 769
2015
Q2
$1.75M Sell
70,988
-50,692
-42% -$1.27M ﹤0.01% 2005
2015
Q1
$3.05M Buy
121,680
+3,032
+3% +$72.1K 0.01% 1689
2014
Q4
$2.74M Sell
118,648
-129,588
-52% -$2.97M 0.01% 1759
2014
Q3
$5.81M Buy
248,236
+121,600
+96% +$2.85M 0.01% 1199
2014
Q2
$2.93M Buy
+126,636
New +$2.8M 0.01% 1530
2013
Q4
Sell
-22,644
Closed -$453K 3772
2013
Q3
$453K Sell
22,644
-183,904
-89% -$3.49M ﹤0.01% 2614
2013
Q2
$3.57M Buy
+206,548
New +$3.43M 0.01% 1238

Other funds holding TECH

Israel Englander's TECH Position: Q2 2026 in Review

Israel Englander opened a new position in Bio-Techne (TECH) in Q2 2026: 989,033 shares worth $69.9M. The stake represents 0.03% of the portfolio and ranks #705 among its holdings. This is a return to the name: Israel Englander previously reported a position in TECH as recently as Q4 2025.

Israel Englander first reported a position in TECH in Q2 2013 and has held it in 47 quarters since. The position peaked at $102M in Q3 2024. 591 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Israel Englander held 989,033 shares of Bio-Techne worth $69.9M as of Q2 2026.
  • Bio-Techne was a new Israel Englander position in Q2 2026.
  • Bio-Techne made up 0.03% of Israel Englander's portfolio in Q2 2026, its #705 holding.
  • Israel Englander first reported a position in Bio-Techne in Q2 2013 and has held it in 47 quarters since.
  • Israel Englander's Bio-Techne position peaked at $102M in Q3 2024.
  • 591 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.